• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edgewise Therapeutics Inc (NQ: EWTX )

    31.44 -1.43 (-4.35%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 933,069
    Open 33.01
    Bid (Size) 29.00 (100)
    Ask (Size) 40.00 (8)
    Prev. Close 32.87
    Today's Range 31.38 - 33.21
    52wk Range 5.930 - 38.12
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    From Edgewise Therapeutics
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga

    Performance

    YTD
    +185.82%
    +185.82%
    1 Month
    -11.61%
    -11.61%
    3 Month
    +67.06%
    +67.06%
    6 Month
    +67.50%
    +67.50%
    1 Year
    +388.96%
    +388.96%

    More News

    Read More
    Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
    From Edgewise Therapeutics
    Via Business Wire
    MarketBeat Week in Review – 9/23 - 9/27
    Via MarketBeat
    Topics Economy
    Exposures Economy Interest Rates
    Analysts Think There's Still Time to Get in on Edgewise, Up 332%
    Via MarketBeat
    Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Crude Oil Gains Over 1%; Mobileye Global Shares Jump
    Via Benzinga
    Exposures Fossil Fuels
    Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
    Via MarketBeat
    Why Edgewise Therapeutics Stock Is Up 50% on Thursday
    Via The Motley Fool
    Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment
    Via Benzinga
    Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Edgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares Dip
    Via Investor's Business Daily
    Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
    From Edgewise Therapeutics
    Via Business Wire
    Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
    From Edgewise Therapeutics
    Via Business Wire
    EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
    From Edgewise Therapeutics
    Via Business Wire
    7 Small-Cap Stocks to Buy for Large-Scale Gains
    Via InvestorPlace
    Stock Market News For July 23: Quick Takes On GE Aerospace, Boeing, Biotechs
    Via Investor's Business Daily
    Topics Government
    Exposures Political
    Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense
    Via Investor's Business Daily
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    Via Investor's Business Daily
    Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
    From Edgewise Therapeutics
    Via Business Wire
    EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
    Via Benzinga
    Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    From Edgewise Therapeutics
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.